GSK's Penmenvy wins FDA approval to protect against five meningococcal serogroups. The CDC panel will vote on usage ...

They're all talking about HPV, or human papillomavirus. It's the most common sexually transmitted infection, but it's also ...

Minnesota’s adolescent immunization rates increased in 2014, according to new data released today by the Centers for Disease ...

On Friday, February 14, the FDA approved GSK plc’s (NYSE:GSK) Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for use in individuals aged 10 through 25. The vaccine targets five major ...

UNICEF supplies and services support adolescent girls and help to ensure a safe environment where they can learn and thrive.

The U.S. Food and Drug Administration has approved Penmenvy (Meningococcal Groups A, B, C, W, and Y Vaccine) for acti ...

When asked their opinions on various childhood or adolescent vaccines, student responses ranged. Almost all respondents indicated the MMR vaccine is important (96 percent), but fewer saw influenza (71 ...

In its first meeting of 2025, the European Medicines Agency (EMA) Committee for Medicinal Products for Human Use (CHMP) gave the green light for the first vaccine in the EU to protect adolescents ...

The approvals come as Robert F. Kennedy Jr.—who has been critical of vaccines—takes leadership of the Department of Health ...

With any vaccine, some people can have dizziness or fainting, and it’s more common in adolescents, Grella said. Adolescents are more likely to have anxiety before the vaccine, feel relieved ...

Adult and pediatric patients who received 2023-2024 influenza vaccines exhibited reduced risk for influenza-associated encounters across care settings.